Home / Expertise / Corporate / M&A
abstract glass form

Corporate / M&A

International

Whether you are planning a merger as part of your growth strategy, thinking about diversifying into new sectors or looking for new funding options such as non-bank lending or through equity investment, our experts offer you the right mix of legal and commercial advice. Having lawyers who think and act beyond their traditional role and seek to add value can help you secure the competitive edge you need in an ever-changing business environment. Our international team of more than 700 corporate lawyers in over 33 countries worldwide can assist you in all aspects of corporate law and M&A, both domestically and internationally.

Whatever your size, a large publicly listed company or a small privately owned business, we can deliver a tailored, commercial, cost effective solution for you, covering areas such as M&A, private equity, equity capital markets, outsourcing, group restructuring and privatisations. Our cross-border teams consist of experts from all practice areas and sectors such as banking, consumer products, energy, infrastructure, insurance, lifesciences, real estate and construction, hotels and leisure, technology and media. This allows us to understand your specific issues for a transaction and provide you with advice within context, saving time and money and allows us to pinpoint your real commercial issues and risks in a transaction.

Read more Read less
June 2020
CMS Cor­por­ate / M&A Glob­al Bro­chure
A glob­al lead­er in Cor­por­ate / M&AWe ad­vise some of the world’s lead­ing com­pan­ies on mer­gers & ac­quis­i­tions, of­ten in chal­len­ging and cross-bor­der situ­ations. With more than 1,000 law­yers of­fer­ing best-in-class leg­al ex­pert­ise across 41 jur­is­dic­tions, we de­liv­er a seam­less cli­ent ex­per­i­ence and in­vari­ably re­ceive top rank­ings from in­dustry com­ment­at­ors in­clud­ing Bloomberg, Mer­ger­mar­ket and Thom­son Re­u­ters.
March 2019
CMS European M&A Study 2019
The CMS Cor­por­ate/M&A group is pleased to launch the el­ev­enth edi­tion of our European M&A Study. video560560ht­tps://me­dia.cmsleg­al.com/me­dia/em­bed?unique_key=bfd4ddebbe2c42442e25ca7daaa0c5d9&width=720&height=405&auto­play=false&auto­light­soff=false&loop=false&clean1This year’s Study re­flects data from 458 deals in 2018 on which CMS ad­vised. This is the largest num­ber of deals ever covered by the Study, now in its 11th year, which is re­flect­ive of CMS’s gain in mar­ket share and cor­res­pond­ing rise up the M&A league tables. In ana­lys­ing the 2018 mar­ket, we re­port on cur­rent mar­ket stand­ards on risk al­loc­a­tion in M&A deals, com­par­ing 2018 against 2017 and the pre­vi­ous eight-year av­er­age for 2010 – 2017.The spe­cial fea­tures of the Study are as fol­lows:CMS Trend In­dex – to il­lus­trate a cur­rent fact or trend for the par­tic­u­lar fea­ture re­por­ted on, com­par­ing the po­s­i­tion in 2018 with that of 2017 and / or the eight-year peri­od 2010 – 2017.CMS European / US risk al­loc­a­tion com­par­is­on – a head­line ana­lys­is of the dif­fer­ing risk al­loc­a­tion on stand­ard is­sues in European and US M&A.CMS European re­gion­al dif­fer­ences – we high­light cer­tain is­sues which are par­tic­u­lar to one or more of the six European re­gions covered.CMS deal size ana­lys­is – we ana­lysed our data against three dif­fer­ent deal val­ues: deals up to EUR 25m; EUR 25m to 100m and deals ex­ceed­ing EUR 100m.For the first time, the Study sought to eval­u­ate the main deal driver for each trans­ac­tion re­viewed. This is in ad­di­tion to ana­lys­is of the back­ground of the seller (mostly stra­tegic and fin­ance in­vestors but also a sub­stan­tial num­ber of in­di­vidu­als) and the buy­er (al­most ex­clus­ively stra­tegic and fin­ance in­vestors).The key find­ings of the Study in­clude:De­creased use of pur­chase price ad­just­ments (PPA) – around 44 per­cent of deals in­cluded a PPA com­pared with 48 per­cent in 2017. This rep­res­ents a not­able move­ment against the over­all trend in re­cent yearsSig­ni­fic­ant in­crease in the ap­plic­a­tion of locked box struc­tures – of the deals that did not in­volve a PPA, 59 per­cent used a locked box in 2018 which rep­res­ents a sig­ni­fic­ant in­crease over the 49 per­cent in 2017Earn-outs con­tin­ue to grow in pop­ular­ity – there was a two-per­cent­age point year on year in­crease in the use of earn-outs in 2018. A quarter of small and mid-cap deals now in­volve earn-outsA re­cord year for War­ranty & In­dem­nity (W&I) in­sur­ance –sellers are in­creas­ingly of­f­load­ing their war­ranty ex­pos­ure by pre-pack­aging a buy­er’s W&I policy. Nearly a third (30 per­cent) of deals val­ued over EUR 100m now in­volve this form of in­sur­anceWe trust that the CMS European M&A Study will as­sist you in your every­day M&A activ­it­ies. 560340ht­tps://form.jot­formeu.com/907841564583671
CMS Ex­pert Guides
Easy ac­cess to ex­pert ad­vice that’s rel­ev­ant to you

Feed

Show only
31 July 2020
An­nu­al Re­view 2019 – 2020
09 June 2020
CMS Ex­pert Guide to in­solv­ency in Lat­in Amer­ica
CMS Ex­pert Guide to In­solv­ency in Lat­in Amer­ica has been pre­pared in or­der to provide an in­tro­duc­tion and brief ex­plan­a­tion of cer­tain in­solv­ency is­sues that have be­come rel­ev­ant in the cur­rent con­text in the fol­low­ing jur­is­dic­tions:  Chile, Colom­bia, Mex­ico and Peru.
10 September 2020
We­bin­ar: What EU policy means for hy­dro­gen pro­jects
Has the time come for em­bra­cing
16 July 2020
Do earn-out clauses help with M&A trans­ac­tions in­flu­enced by COV­ID-19?
In times of COV­ID-19, many trans­ac­tions are dif­fi­cult to ne­go­ti­ate, par­tic­u­larly when it comes to the pur­chase price. Can earn-out clauses be of any help? This is a ques­tion that needs to be answered...
26 June 2020
The Lat­in Amer­ic­an GC: Rising to the chal­lenge
12 May 2020
CMS Ex­pert Guide for dir­ect­ors of com­pan­ies
12 May 2020
Ad­vising the Board on In­solv­ency Risk in Singa­pore
This art­icle is pro­duced by CMS Hol­born Asia, a Form­al Law Al­li­ance between CMS Singa­pore and Hol­born Law LLC. Im­pact of COV­ID-19 on cor­por­ate fail­ures and dir­ect­ors’ con­duct Giv­en the un­cer­tain­ties...
22 June 2020
The Lat­in Amer­ic­an Gen­er­al Coun­sel
The first CMS Gen­er­al Coun­sel re­port in the Lat­in Amer­ica re­gion ex­plores the de­vel­op­ment of the GC role and how the world in which GCs work im­pacts them
26 March 2020
CMS Ex­pert Guide to sta­bil­isa­tion and re­struc­tur­ing ini­ti­at­ive
11 May 2020
Dir­ect­ors Du­ties in the UAE: Part 3 – Du­ties in times of Fin­an­cial Un­cer­tainty
In­tro­duc­tion With glob­al eco­nom­ies fa­cing un­cer­tain times as a res­ult of the COV­ID-19 pan­dem­ic, and many busi­nesses fa­cing sig­ni­fic­ant chal­lenges to cash flow, rev­en­ue and bad debts, the pos­sib­il­ity of...
9 June 2020
Im­pact of COV­ID-19 on European M&A activ­ity
The CMS Cor­por­ate/M&A Group teamed up with in­vest­ment bank Cred­it Suisse to ana­lyse the fin­an­cial and leg­al im­plic­a­tions of the COV­ID-19 pan­dem­ic on M&A trans­ac­tions in West­ern Europe.
05 November 2018
CMS Ex­pert Guide to the trans­par­ency re­gister in AML dir­ect­ive
Are you look­ing for in­form­a­tion on the trans­par­ency re­gister in the 4th AML dir­ect­ive? Learn everything about it in this CMS Ex­pert Guide.